Protagonist Therapeutics
PTGX
#3859
Rank
NZ$4.34 B
Marketcap
$72.82
Share price
-7.16%
Change (1 day)
171.84%
Change (1 year)

Earnings for Protagonist Therapeutics (PTGX)

Earnings in 2024 (TTM): NZ$0.28 Billion

According to Protagonist Therapeutics 's latest financial reports the company's current earnings are NZ$0.31 Billion. In 2023 the company made an earning of -NZ$0.14 Billion, an increase over its 2022 earnings that were of -NZ$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protagonist Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.28 B-316.25%
2023 -NZ$0.14 Billion-38.02%
2022 -NZ$0.22 Billion1.47%
2021 -NZ$0.22 Billion93.62%
2020 -NZ$0.11 Billion-16.74%
2019 -NZ$0.14 Billion96.06%
2018 -NZ$67.01 Million7.48%
2017 -NZ$62.35 Million-0.59%
2016 -NZ$62.72 Million150.22%
2015 -NZ$25.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.22 Billion-172.49%๐Ÿ‡บ๐Ÿ‡ธ USA